Board

William P. (Bill) Moffitt
Chairman
Bill is accomplished board chairman with a proven track record of leading companies --- of all market capitalizations, public and private --- in the rapid development...
... of cutting-edge technologies and the commercialization of products and solutions that have helped shape the healthcare industry.  He has led multiple companies to successful exits via both initial public offerings and trade sales to strategic partners. 
read more...
Nadia Whittley
CHIEF EXECUTIVE OFFICER
Nadia is a highly skilled senior executive in the Life Sciences sector with experience across several therapeutic areas and spanning EMEA, Asia Pacific and North America...
...She has held senior positions at Alium Medical Limited, Allergan, Boston Scientific and Medtronic. Most recently Nadia served as the Partner & Managing Director Europe for Tefen Management Consulting. Nadia has a strong background in business management and product commercialisation.
read more...
Rob Jones
Chief Financial Officer
Rob is an experienced chartered accountant with a background in corporate finance. Having trained and qualified with PwC, over the last 15 years he has worked...
...within corporate finance lead advisory, VC investment and industry. He has significant experience in fundraising, financial modelling, due diligence and broader SME management.
read more...
Sarah Couch
Chief Technical Officer
Sarah has a technical background in assay development, with over 16 years’ practical experience of R&D, quality and regulatory affairs in the IVD industry at Dako and Thermo...
... Fisher Scientific. She has extensive experience of the IVD product cycle from product initiation through to launch and beyond. Since 2011, Sarah has provided a wide range of assistance to IVD start-ups, focusing mainly on regulatory compliance and quality management.
read more...
David Denny
Non-Executive Director
David represents Longwall Ventures, a key investor in Arquer. He started his career as a graduate engineer in Carnaud Metalbox (now Crown Cork), working in a range...
...of roles from R&D to production and project management. David spent much of his career living and working overseas in Spain, Argentina, Belgium and France. David studied for his MBA at Harvard Business School, after which he joined Z Corporation, an MIT licensee start-up. He spent several years growing the European and Asian businesses before entering the venture industry. David predominantly focuses on physical science and engineering investment opportunities.
read more...
Dr Alex Buchan
Observer
Alex represents Northstar Ventures, a key investor in Arquer. He joined Northstar in September 2004 following a series of senior commercial roles in the biotechnology...
...sector, including Cybersense, Compugen, SDI Europe, EnSys Europe and Archaeus. Alex completed a PhD in Microbiology before spending three years in London as a stockbroker for UBS Phillips and Drew.
read more...
Dr Nick Miller-Jones
Founder and Non-Executive Director
Nick has over 20 years’ experience in the biotech, life sciences and healthcare industries, including leading the Life Sciences division of Scientific Generics, one...
...of the UK’s leading technology consultancy companies. He has worked in several disciplines, including lab-based point-of-care assay development, market analysis and positioning, and market entry strategy. Nick is skilled at identifying companies for acquisition and performing due diligence on life sciences companies on behalf of investors.
read more...